Fact checked byMindy Valcarcel, MS

Read more

December 24, 2023
1 min read
Save

Radiation oncologist to lead NYU Langone Health’s Perlmutter Cancer Center

Fact checked byMindy Valcarcel, MS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Alec Kimmelman, MD, PhD, has been appointed director of Perlmutter Cancer Center at NYU Langone Health.

Kimmelman, a radiation oncologist whose research focuses on the biology of pancreatic cancer, will continue to serve as Anita Steckler and Joseph Steckler chair of the department of radiation oncology at NYU Grossman School of Medicine.

Graphic with quote from Alec Kimmelman, MD, PhD

“This is an incredible opportunity,” Kimmelman said in a press release. “My time leading the department of radiation oncology has given me the chance to collaborate with excellent teams all across the institution, and I am confident that together we will continue to lead the charge in developing new treatments and providing our patients with the world-class care for which we are known. The considerable talent we have already attracted to Perlmutter Cancer Center makes clear that this is one of the most exciting cancer programs anywhere.”

Kimmelman — who joined NYU Langone in 2016 — also co-leads the cancer center’s cancer cell biology program and serves on its executive management committee.

“Dr. Kimmelman’s work consistently and clearly demonstrates all of the necessary talents and skills needed to effectively lead our cancer program into the future,” Robert I. Grossman, MD, dean and CEO of NYU Langone, said in the release. “Perlmutter Cancer Center’s groundbreaking cancer research, state-of-the-art treatment, and impactful prevention and education programs are exemplars of our institution’s exceptionalism. We are confident that the center will continue this upward trajectory under Dr. Kimmelman’s leadership.”